Description

Adenosylhomocysteinase (SAHH; AHCY) is a highly conserved enzyme. Adenosylhomocysteinase reversible catalyzes S-adenosylhomocysteine (SAH) to adenosine and L-homocysteine. The serum exosomal Adenosylhomocysteinase level can be used as a prognostic biomarker in HBV-LC patients[1][2].–Applications-Metabolism-protein/nucleotide metabolism-Formula-N/A-Citation–References-[1]Tong L, et al. Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis. Front Med (Lausanne). 2021 Nov 8;8:777452.|[2]Vizán P, Di Croce L, Aranda S. Functional and Pathological Roles of AHCY. Front Cell Dev Biol. 2021 Mar 31;9:654344. -CASNumber-9025-54-1-MolecularWeight-N/A-Compound Purity–SMILES-[Adenosylhomocysteinase]-Research_Area-Infection; Metabolic Disease-Solubility-10 mM in DMSO-Target-Endogenous Metabolite;HBV-Isoform–Pathway-Anti-infection;Metabolic Enzyme/Protease-MCE Product type-Enzyme